Sign in
Not yet taking people in United StatesNo phase

Testing AI text messages to encourage exercise in people with type 2 diabetes

Tests AI text messages to encourage exercise and wellbeing in adults with diabetes.

Key facts

Who runs it
Massachusetts General Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Developing Resiliency and Exercise Using AI-based Messaging
Status
Not yet recruiting
People taking part
20 people, planned
Started
1 Sept 2026
Expected to end
31 Mar 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • DREAM
Record updated
18 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes who do not get enough physical activity. It tests an 8-week message program to promote physical activity and well-being.

Age
Adults (no exact age range is given in the record).
Sex
All sexes can join.
Disease stage
Type 2 diabetes (A1c ≥6.5% (48 mmol/mol), fasting glucose ≥126 mg/dL (7 mmol/L)) with low physical activity (score < 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item).
Earlier treatment
People using non-basal insulin cannot join. People in any other program focused on physical activity or well-being cannot join.

Main reasons for not taking part

  • Another condition that limits physical activity
  • Taking part in another program on physical activity or well-being
  • A cognitive problem that prevents taking part or giving informed consent
  • Current pregnancy or plan to become pregnant in the next 16 weeks
  • Cannot speak or write fluently in English

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Type 2 diabetes diagnosis (A1c ≥6.5%, fasting glucose ≥126 mg/dL)
  • Suboptimal physical activity (score < 5 on the Medical Outcomes Study Specific Adherence Scale physical activity item)
  • Access to a smartphone (i.e., Android or iOS) or computer with access to the internet and an internet browser

Who cannot take part

  • An unrelated condition limiting physical activity
  • Participation in any other programs focused on physical activity or well-being
  • A cognitive disturbance precluding participation or informed consent
  • Current pregnancy or plan to become pregnant in the next 16 weeks
  • Inability to speak/write fluently in English
  • Use of non-basal insulin

Where in United States

  • Massachusetts General HospitalBoston, United StatesContact: Christopher M Celano, M.D.Not yet recruiting

About the trial

What the trial wants to find out

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the DREAM program, an 8-week message-based intervention to promote physical activity and well-being in adults with type 2 diabetes.

The 2 groups in the trial

  • DREAMTreatment being tested

    Participants will engage in twice weekly, interactive messaging sessions with DREAM, a computer-based messaging system designed to help people engage in more physical activity and improve overall well-being. In the first session of each week, participants will set a physical activity goal and learn a new positive psychology topic. They will review goals and topics from the prior week. In the second session, participants will be reminded of the goals set during the first messaging session earlier that week. The program will run for eight weeks.

  • Wait-list controlNo study treatment, for comparison

    Participants in the wait-list control condition will engage in usual medical care for eight weeks, then will complete the DREAM program.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Developing Resiliency and Exercise Using AI-based Messaging: The DREAM Pilot Study
Plain-language title
Testing AI text messages to encourage exercise in people with type 2 diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
18 May 2026